Faralimomab
Faralimomab
Faralimomab (pronunciation: fah-rah-lee-moh-mab) is a monoclonal antibody designed for the treatment of various medical conditions.
Etymology
The name "Faralimomab" is derived from the International Nonproprietary Names (INN), where "mab" at the end signifies it as a monoclonal antibody. The prefix "Fara" is arbitrary and does not carry a specific meaning.
Usage
Faralimomab is used in the field of medicine and pharmacology for the treatment of diseases. As a monoclonal antibody, it is designed to target and bind to specific cells or proteins, which stimulates the patient's immune system to attack those cells.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Pharmacology: The branch of medicine that deals with the uses, effects, and modes of action of drugs.
- Medicine: The science and practice of diagnosing, treating, or preventing disease and other damage to the body or mind.
See Also
External links
- Medical encyclopedia article on Faralimomab
- Wikipedia's article - Faralimomab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski